Osteogenic effect of interleukin-11 and synergism with ascorbic acid in human periodontal ligament cells

Journal of Periodontal Research

Volumn 42, Issue 6, 2007, Pages 527-535

  Leon, E R ^a   Iwasaki, K ^a   Komaki, M ^a   Kojima, T ^a   Ishikawa, I ^a,b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Ascorbic acid; Interleukin 11; Osteoblastic differentiation; Periodontal ligament cells

Indexed keywords

ALKALINE PHOSPHATASE; ASCORBIC ACID; BONE SIALOPROTEIN; COLLAGEN TYPE 1; INTERLEUKIN 11; JANUS KINASE; OSTEOCALCIN; RUNX2 PROTEIN, HUMAN; SIALOGLYCOPROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; DRUG EFFECT; DRUG POTENTIATION; HUMAN; METABOLISM; OSTEOBLAST; PERIODONTAL LIGAMENT; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ALKALINE PHOSPHATASE; ASCORBIC ACID; CELL DIFFERENTIATION; CELLS, CULTURED; COLLAGEN TYPE I; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DRUG SYNERGISM; HUMANS; INTERLEUKIN-11; JANUS KINASES; MAP KINASE SIGNALING SYSTEM; OSTEOBLASTS; OSTEOCALCIN; PERIODONTAL LIGAMENT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIALOGLYCOPROTEINS; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 35348939206     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2007.00977.x     Document Type: Article

References (48)

1. Arceo N, Sauk JJ, Moehring J, Foster RA, Somerman MJ. Human periodontal cells initiate mineral-like nodules in vitro. J Periodontol 1991 62 : 499 503.
2. Ivanovski S, Li H, Haase HR, Bartold PM. Expression of bone associated macromolecules by gingival and periodontal ligament fibroblasts. J Periodont Res 2001 36 : 131 141.
3. Bartold PM, Shi S, Gronthos S. Stem cells and periodontal regeneration. Periodontol 2000 2006 40 : 164 172.
4. Nagatomo K, Komaki M, Sekiya I et al. Stem cell properties of human periodontal ligament cells. J Periodont Res 2006 41 : 303 310.
5. Xiao G, Cui Y, Ducy P, Karsenty G, Franceschi RT. Ascorbic acid-dependent activation of the osteocalcin promoter in MC3T3-E1 preosteoblasts: requirement for collagen matrix synthesis and the presence of an intact OSE2 sequence. Mol Endocrinol 1997 11 : 1103 1113.
6. Iqbal K, Khan A, Muzaffar M. Biological significance of ascorbic acid (vitamin C) in health - A review. Pak J Nutr 2004 3 : 5 13.
7. Hayami T, Zhang Q, Kapila Y, Kapila S. Dexamethasone's enhancement of osteoblastic markers in human periodontal ligament cells is associated with inhibition of collagenase expression. Bone 2007 40 : 93 104.
8. Giancotti FG, Ruoslahti E. Integrin signaling. Science 1999 285 : 1028 1032.
9. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell 2002 110 : 673 687.
10. Ishikawa S, Iwasaki K, Komaki M, Ishikawa I. Role of ascorbic acid in periodontal ligament cell differentiation. J Periodontol 2004 75 : 709 716.
11. Heinrich PC, Behrmann I, Muller-Newen G, Schaper F, Graeve L. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem J 1998 334 : 297 314.
12. Tacken I, Dahmen H, Boisteau O et al. Definition of receptor binding sites on human interleukin-11 by molecular modeling-guided mutagenesis. Eur J Biochem 1999 265 : 645 655.
13. Anusaksathien O, Giannobile WV. Growth factor delivery to re-engineer periodontal tissues. Curr Pharm Biotechnol 2002 3 : 129 139.
14. Du X, Williams DA. Interleukin-11: review of molecular, cell biology, and clinical use. Blood 1997 89 : 3897 3908.
15. Yashiro R, Nagasawa T, Kiji M et al. Transforming growth factor-beta stimulates interleukin-11 production by human periodontal ligament and gingival fibroblasts. J Clin Periodontol 2006 33 : 165 171.
16. James C, Keith J. Interleukin-11. In : Angus W, Thomson MTL, eds. The Cytokine Handbook, 4th edn. Pittsburg, USA : Academic Press, 2003 : 363 381.
17. Keller DCXX, Srour EF, Hoffman R, Williams DA. Interleukin-11 inhibits adipogenesis and stimulates myelopoiesis in human long-term marrow cultures. Blood 1993 82 : 1428 1435.
18. Tenney R, Stansfield K, Pekala PH. Interleukin 11 signaling in 3T3-L1 adipocytes. J Cell Physiol 2005 202 : 160 166.
19. Trepicchio WL, Bozza M, Pedneault G, Dorner AJ. Recombinant human IL-11 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide production. J Immunol 1996 157 : 3627 3634.
20. Johnson RB, Wood N, Serio FG. Interleukin-11 and IL-17 and the pathogenesis of periodontal disease. J Periodontol 2004 75 : 37 43.
21. Dovio A, Sartori ML, Masera RG et al. Autocrine down-regulation of glucocorticoid receptors by interleukin-11 in human osteoblast-like cell lines. J Endocrinol 2003 177 : 109 117.
22. Maier R, Ganu V, Lotz M. Interleukin-11, an inducible cytokine in human articular chondrocytes and synoviocytes, stimulates the production of the tissue inhibitor of metalloproteinases. J Biol Chem 1993 268 : 21527 21532.
23. Hermann JA, Hall MA, Maini RN, Feldmann M, Brennan FM. Important immunoregulatory role of interleukin-11 in the inflammatory process in rheumatoid arthritis. Arthritis Rheum 1998 41 : 1388 1397.
24. Romas E, Udagawa N, Zhou H et al. The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures. J Exp Med 1996 183 : 2581 2591.
25. Martuscelli G, Fiorellini JP, Crohin CC, Howell TH. The effect of interleukin-11 on the progression of ligature-induced periodontal disease in the beagle dog. J Periodontol 2000 71 : 573 578.
26. Suga K, Saitoh M, Fukushima S et al. Interleukin-11 induces osteoblast differentiation and acts synergistically with bone morphogenetic protein-2 in C3H10T1/2 cells. J Interferon Cytokine Res 2001 21 : 695 707.
27. Katagiri T, Takahashi N. Regulatory mechanisms of osteoblast and osteoclast differentiation. Oral Dis 2002 8 : 147 159.
28. Takeuchi Y, Watanabe S, Ishii G et al. Interleukin-11 as a stimulatory factor for bone formation prevents bone loss with advancing age in mice. J Biol Chem 2002 277 : 49011 49018.
29. Suga K, Saitoh M, Kokubo S et al. Interleukin-11 acts synergistically with bone morphogenetic protein-2 to accelerate bone formation in a rat ectopic model. J Interferon Cytokine Res 2003 23 : 203 207.
30. Suga K, Saitoh M, Kokubo S et al. Synergism between interleukin-11 and bone morphogenetic protein-2 in the healing of segmental bone defects in a rabbit model. J Interferon Cytokine Res 2004 24 : 343 349.
31. Sims NA, Jenkins BJ, Nakamura A et al. Interleukin-11 receptor signaling is required for normal bone remodeling. J Bone Miner Res 2005 20 : 1093 1102.
32. Kerwar SS. Regulation of collagen synthesis and maturation by 3,4-dehydroproline. Arch Biol Med Exp (Santiago) 1979 12 : 359 366.
33. Tan EM, Ryhanen L, Uitto J. Proline analogues inhibit human skin fibroblast growth and collagen production in culture. J Invest Dermatol 1983 80 : 261 267.
34. Geoffroy V, Marty-Morieux C, Le Goupil N et al. In vivo inhibition of osteoblastic metalloproteinases leads to increased trabecular bone mass. J Bone Miner Res 2004 19 : 811 822.
35. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 2003 374 : 1 20.
36. Xiao G, Gopalakrishnan R, Jiang D, Reith E, Benson MD, Franceschi RT. Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells. J Bone Miner Res 2002 17 : 101 110.
37. Thompson JE, Cubbon RM, Cummings RT et al. Photochemical preparation of a pyridone containing tetracycle: a Jak protein kinase inhibitor. Bioorg Med Chem Lett 2002 12 : 1219 1223.
38. Wang LH, Kirken RA, Erwin RA, Yu CR, Farrar WL. JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response. J Immunol 1999 162 : 3897 3904.
39. Afzal F, Polak J, Buttery L. Endothelial nitric oxide synthase in the control of osteoblastic mineralizing activity and bone integrity. J Pathol 2004 202 : 503 510.
40. Werner D, Chirammal SL. Bone repair and adult stem cells. In : Bongso A, Lee EH, eds. Stem Cells: from Bench to Bedside, 1st edn. Singapore : World Scientific Publishing Co., Pte. Ltd. 2005 : 422 465.
41. Tang W, Geba GP, Zheng T et al. Targeted expression of IL-11 in the murine airway causes lymphocytic inflammation, bronchial remodeling, and airways obstruction. J Clin Invest 1996 98 : 2845 2853.
42. Franceschi RT, Iyer BS, Cui Y. Effects of ascorbic acid on collagen matrix formation and osteoblast differentiation in murine MC3T3-E1 cells. J Bone Miner Res 1994 9 : 843 854.
43. Franceschi RT. The developmental control of osteoblast-specific gene expression: role of specific transcription factors and the extracellular matrix environment. Crit Rev Oral Biol Med 1999 10 : 40 57.
44. Ganss B, Kim RH, Sodek J. Bone sialoprotein. Crit Rev Oral Biol Med 1999 10 : 79 98.
45. Stamenkovic I. Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol 2003 200 : 448 464.
46. Sims NA, Jenkins BJ, Quinn JM et al. Glycoprotein 130 regulates bone turnover and bone size by distinct downstream signaling pathways. J Clin Invest 2004 113 : 379 389.
47. Shin HI, Divieti P, Sims NA et al. Gp130-mediated signaling is necessary for normal osteoblastic function in vivo and in vitro. Endocrinology 2004 145 : 1376 1385.
48. Xiao G, Jiang D, Thomas P et al. MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor, Cbfa1. J Biol Chem 2000 275 : 4453 4459.